Loading
Latest filing published 13 Dec 2022 for Bellerophon Therapeutics, Inc.. Read the official filing
No signal scores available.
Martin Dekker is a declared insider of Bellerophon Therapeutics, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 19 January 2016 to 9 December 2022, the count stands at 2 filings.
The filings describe grants, exercises and other transfers rather than trades on the open market. Grants and option exercises follow pay plans set in advance, so they reveal less about an insider's own view than a purchase made with personal money.
On 13 December 2022 came the latest disclosure, an option exercise in Bellerophon Therapeutics, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations